Clinical Trial Update: A Study on the Effects of a Single Dose of Prednisone on Biomarkers of Allergen Responses in Asthmatics (MK-0000-175) [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated the effect of a single dose of prednisone on biomarkers of allergen responses in asthmatics, with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• PREDNISONE (Prednisone)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Asthma | Phase 1 | Status: COMPLETED | Results posted: 2012-08-02